Phase II Study Examining the Efficacy of Short Fractionation Radiotherapy for the Palliation of Liver Metastases
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Related Post
18 October, 2022
NINJA Radiation Therapy Trial participant tells his journey to treatment
The journey to becoming the 200th participant for the
6 September, 2022
The gift that kept on giving
The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing
